Improvement in oral bioavailability of 2,4-diaminopyrimidine c-Met inhibitors by incorporation of a 3-amidobenzazepin-2-one group by Milkiewicz, Karen L., Aimone, Lisa D., Albom, Mark S., Angeles, Thelma S., Chang, Hong, Grobelny, Jennifer V., Husten, Jean, LoSardo, Christine, Miknyoczki, Sheila, Murthy, Seetha, Rolon-Steele, Damaris, Underiner, Ted L., Weinberg, Linda R., Worrell, Candace S., Zeigler, Kelli S., Dorsey, Bruce D.

Get full text

2,4-Diaminopyrimidine inhibitors of c-Met kinase bearing benzoxazepine anilines by Zificsak, Craig A., Theroff, Jay P., Aimone, Lisa D., Albom, Mark S., Angeles, Thelma S., Brown, Rebecca A., Galinis, Deborah, Grobelny, Jennifer V., Herbertz, Torsten, Husten, Jean, Kocsis, Laura S., LoSardo, Christine, Miknyoczki, Sheila J., Murthy, Seetha, Rolon-Steele, Damaris, Underiner, Ted L., Wells-Knecht, Kevin J., Worrell, Candace S., Zeigler, Kelli S., Dorsey, Bruce D.

Get full text